Free Trial

Scienture Q3 2023 Earnings Report

$4.26 -0.37 (-8.03%)
As of 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Scienture EPS Results

Actual EPS
-$0.07
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Scienture Revenue Results

Actual Revenue
$2.06 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Scienture Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Scienture Earnings Headlines

Do this Before Elon’s Reveal on January 29th
Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.
See More Scienture Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Scienture? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Scienture and other key companies, straight to your email.

About Scienture

Scienture (NASDAQ:SCNX) engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.

View Scienture Profile

More Earnings Resources from MarketBeat